16 research outputs found
The effect of Microcarrier-delivered Keratinocytes and Single-stage Matriderm on Wound Contraction and Epithelialisation
Ex vivo culture of keratinocytes on papillary and reticular dermal layers remodels skin explants differently: towards improved wound care
In this study, we characterised the efect that seeding keratinocytes on the papillary and reticular dermis had on the extracellular matrix and tissue integrity ex vivo. Human skin explants from consented patients (n=6) undergoing routine surgery
were cultured at a liquid–air interface, dermal-side up, and autologous keratinocytes seeded on the exposed papillary or
reticular layer. After 7–21 days, histological and immunohistochemical evaluation of the morphology and extracellular
matrix was performed. While the dermis remained robust in all explants cultures, keratinocytes seeded on the papillary layer
showed less tissue infltration and remodelling and formed clusters across the tissue. In contrast, keratinocytes seeded on the
reticular layer infltrated the tissue homogenously with an intact single-cell-layer surface coverage and structural changes
characterised by increased deposition of ground substance, glycosaminoglycans, and collagen VII in 14 days. In addition,
while the papillary section showed more new laminin deposition by 14 days than the reticular section, the latter expressed
more connexin 43. These diferences in re-epithelialisation and extracellular matrix characteristics suggest that wound depth
and graft thickness may play a key role in wound healing and indicate that ECM characteristics should be factored in when
designing biomaterials for wound applications and in the selection of recipient sites when using cells for grafting
Consensus demonstrates four indicators needed to standardize burn wound infection reporting across trials in a single-country study (ICon-B study)
Protocol for the development of a core indicator set for reporting burn wound infection in trials: ICon-B study
INTRODUCTION: Systematic reviews of high-quality randomised controlled trials are necessary to identify effective interventions to impact burn wound infection (BWI) outcomes. Evidence synthesis requires that BWI is reported in a consistent manner. Cochrane reviews investigating interventions for burns report that the indicators used to diagnose BWI are variable or not described, indicating a need to standardise reporting. BWI is complex and diagnosed by clinician judgement, informed by patient-reported symptoms, clinical signs, serum markers of inflammation and bacteria in the wound. Indicators for reporting BWI should be important for diagnosis, frequently observed in patients with BWI and assessed as part of routine healthcare. A minimum (core) set of indicators of BWI, reported consistently, will facilitate evidence synthesis and support clinical decision-making. AIMS: The Infection Consensus in Burns study aims to identify a core indicator set for reporting the diagnosis of BWI in research studies. METHODS: (1) Evidence review: a systematic review of indicators used in trials and observational studies reporting BWI outcomes to identify a long list of candidate indicators; (2) refinement of the long list into a smaller set of survey questions with an expert steering group; (3) a two-round Delphi survey with 100 multidisciplinary expert stakeholders, to achieve consensus on a short list of indicators; (4) a consensus meeting with expert stakeholders to agree on the BWI core indicator set. ETHICS AND DISSEMINATION: Participants will be recruited through professional bodies, such that ethical approval from the National Health Service (NHS) Health Research Authority (HRA) is not needed. The core indicator set will be disseminated through peer-reviewed publication, co-production with journal editors, research funders and professional bodies, and presentation at national conferences. PROSPERO REGISTRATION NUMBER: CRD42018096647
Managing frostbite
Prevention, using a combination of appropriate behaviour and equipment, is key
Rewarm frostbite as soon as the risk of refreezing is minimal
Seek advice from a specialist unit if the injury is potentially severe
Consider thrombolysis (with tissue plasminogen activator) in severe injuries presenting within 24 hours of exposure
Delay surgery unless there is evidence of compartment syndrome or overwhelming sepsis
People who have sustained a cold injury are more susceptible to a future cold injur